MarketWatch ยท Jun 22, 2026 12:02 UTC AbbVie is buying a biotech company working on an experimental eczema drug for $10.9 billion Read full story on MarketWatch Share AI disclosure Summary Apogee Therapeutics is developing a promising atopic dermatitis drug. Original reporting Open original source Read full article on MarketWatch Get the AFBytes Brief Major stories, AI-assisted analysis, and what to watch next. Free, monthly, unsubscribe anytime. Subscribe
